Cosmos Health Inc. has entered into a significant financing agreement with an institutional investor. The company announced the completion of an Initial Closing under a Securities Purchase Agreement dated August 5, 2025. As part of this agreement, Cosmos Health issued a 9% original issue discount senior secured convertible promissory note with a principal amount of $8 million. The note matures on August 7, 2027, with interest payable in shares of Cosmos Health common stock. This transaction, conducted as a private offering, capitalizes on an exemption from registration under the Securities Act of 1933. The note ranks senior to all current and future indebtedness of the company, barring specific permitted debts.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.